Healthcare service company Molina Healthcare Inc (NYSE:MOH) disclosed on Monday its net income of USD737m (USD11.47 per diluted share) for the year ended 31 December 2019.
This marks a growth when compared with net income of USD707m (USD10.61 per diluted share) for the year ended 31 December 2018.
Total revenues of USD16.83bn were generated in 2019, down over total revenues of USD18.8bn in 2018.
For the full year 2020, the company expects GAAP earnings per diluted share in the range of USD11.20 - USD11.70, as well as premium revenue growth of 7.4%. The guidance reflects the reintroduction of the Health Insurer Fee in 2020 with an impact of approximately USD0.30 per diluted share as well as currently exercising its protest rights on the new STAR+PLUS RFP award.
IP Group positions for future royalties following Pfizer's USD7.3bn acquisition of Metsera
AstraZeneca strikes landmark drug pricing deal with US Government
Fusion Antibodies secures multi-target humanisation contract with global pharmaceutical client
Genmab to acquire Merus in USD8bn deal to strengthen oncology pipeline
Wolters Kluwer launches UpToDate Expert AI to deliver trusted GenAI clinical decision support
Abbott announces quarterly common dividend
CVS Health declares unchanged quarterly dividend
ALK partners with GenSci to expand allergy immunotherapy market in China
Innocan Pharma reports 'positive swing' in operating profitability for first half of 2025
Wolters Kluwer boosts medical research efficiency with Ovid AI summarisation
European Commission approves Gilead's twice-yearly HIV prevention injection Yeytuo
Essa Pharma clarifies Nasdaq due bill trading period for cash distribution
Advanz Pharma and Alvotech secure European approval for aflibercept biosimilar Mynzepli